Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

BENFANTE, Alida
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.406
EU - Europa 2.523
AS - Asia 2.506
Continente sconosciuto - Info sul continente non disponibili 519
SA - Sud America 407
AF - Africa 76
OC - Oceania 6
Totale 12.443
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.250
SG - Singapore 882
RU - Federazione Russa 860
IT - Italia 627
CN - Cina 598
BR - Brasile 317
VN - Vietnam 231
HK - Hong Kong 225
FI - Finlandia 191
BD - Bangladesh 186
PL - Polonia 160
DE - Germania 154
GB - Regno Unito 117
FR - Francia 97
CA - Canada 85
JP - Giappone 85
UA - Ucraina 78
IE - Irlanda 70
KR - Corea 62
IN - India 57
NL - Olanda 48
IQ - Iraq 24
MX - Messico 24
TR - Turchia 24
ZA - Sudafrica 23
AR - Argentina 20
SE - Svezia 20
ID - Indonesia 19
PK - Pakistan 19
ES - Italia 17
CO - Colombia 14
AT - Austria 13
JM - Giamaica 13
SA - Arabia Saudita 13
VE - Venezuela 13
CI - Costa d'Avorio 12
MA - Marocco 12
RO - Romania 12
AE - Emirati Arabi Uniti 11
CH - Svizzera 11
CL - Cile 11
MY - Malesia 11
BE - Belgio 10
EC - Ecuador 9
CZ - Repubblica Ceca 8
GR - Grecia 8
UY - Uruguay 8
CR - Costa Rica 7
KE - Kenya 7
NP - Nepal 7
PY - Paraguay 7
UZ - Uzbekistan 7
AU - Australia 6
HN - Honduras 6
IR - Iran 6
NI - Nicaragua 6
BG - Bulgaria 5
ET - Etiopia 5
JO - Giordania 5
BO - Bolivia 4
LB - Libano 4
PE - Perù 4
PH - Filippine 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
EG - Egitto 3
GT - Guatemala 3
IL - Israele 3
KZ - Kazakistan 3
LT - Lituania 3
OM - Oman 3
PT - Portogallo 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
DZ - Algeria 2
KG - Kirghizistan 2
MM - Myanmar 2
MQ - Martinica 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
BB - Barbados 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
GP - Guadalupe 1
HR - Croazia 1
KH - Cambogia 1
LV - Lettonia 1
MD - Moldavia 1
Totale 11.917
Salva come PNG Salva come JPEG
Città #
Ashburn 772
Fairfield 737
Singapore 578
San Jose 377
Woodbridge 336
Chandler 322
Seattle 290
Cambridge 283
Houston 273
Wilmington 273
Hong Kong 220
Council Bluffs 171
Zgierz 143
Moscow 141
Des Moines 133
Ann Arbor 112
Beijing 108
Los Angeles 107
New York 100
Medford 91
Santa Clara 90
Helsinki 88
Dallas 83
Tokyo 81
Ho Chi Minh City 79
Hanoi 71
Dublin 69
Palermo 69
Altamura 63
Lauterbourg 59
Princeton 57
Nanjing 56
Lawrence 49
Boardman 46
The Dalles 46
Buffalo 45
Chicago 44
San Diego 44
Hefei 40
Frankfurt am Main 37
Milan 37
Jacksonville 35
London 33
Dearborn 32
Naples 30
Rome 29
São Paulo 28
Seoul 26
Orem 25
Jinan 22
Toronto 22
Atlanta 21
Shenyang 21
Ludwigshafen am Rhein 20
Montreal 19
Nuremberg 18
Phoenix 18
Tianjin 18
Falls Church 16
Changsha 15
Kilburn 15
Amsterdam 14
San Paolo di Civitate 14
Chennai 13
Johannesburg 13
Tulsa 13
Abidjan 12
Denver 12
Hebei 12
Lappeenranta 12
North Bergen 12
Zhengzhou 12
Haiphong 11
Nanchang 11
Brooklyn 10
Brussels 10
Columbus 10
Salt Lake City 10
Vancouver 10
Verona 10
Warsaw 10
Bologna 9
Boston 9
Jiaxing 9
Kingston 9
Lahore 9
Manchester 9
Mexico City 9
Paris 9
Pune 9
Rio de Janeiro 9
Shanghai 9
Stockholm 9
Baghdad 8
Catania 8
Guangzhou 8
Harbin 8
Kuala Lumpur 8
Norwalk 8
Riyadh 8
Totale 7.678
Salva come PNG Salva come JPEG
Nome #
Airway distensibility by HRCT in asthmatics and COPD with comparable airway obstruction 293
Arterial stiffness in symptomatic smokers with normal lung function 282
Asthmatics with high levels of serum surfactant protein D have more severe disease 276
Asthma in the elderly: A different disease? 260
Prevalence of arterial hypertension and characteristics of nocturnal blood pressure profile of asthma patients according to therapy and severity of the disease: The bada study 260
Dynamic hyperinflation during the 6-min walk test in severely asthmatic subjects 257
Challenges in the pharmacological treatment of geriatric asthma 246
Early Lung Function Abnormalities in Acromegaly. 236
Serum low density lipoprotein subclasses in asthma 233
How Effective and Safe Is Bronchial Thermoplasty in "real Life" Asthmatics Compared to Those Enrolled in Randomized Clinical Trials? 220
Asthma in the older adult: Presentation, considerations and clinical management 218
Exhaled nitric oxide is associated with cyclic changes in sexual hormones 216
Validation of lung densitometry threshold at CT for the distinction between senile lung and emphysema in elderly subjects. 211
Airway Wall Thickness By HRCT Does Not Affect Airway Distensibility In Asthma And COPD 209
Are biological drugs effective and safe in older severe asthmatics? 205
Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics 205
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD 201
Does the frequency of switching inhalers represent a predictive factor of exacerbation in asthma? 200
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 193
Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients 192
Lung penetration and patient adherence considerations in the management of asthma: Role of extra-fine formulations 185
Urinary Incontinence in Chronic Obstructive Pulmonary Disease: A Common Co-morbidity or a Typical Adverse Effect? 185
Densitometria TC nella diagnosi radiologica differenziale tra polmone senile ed enfisema nell’ anziano 183
Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD 181
Effects of a structured educational intervention in moderate-to-severe elderly asthmatic subjects 181
Management of suspected COVID-19 patients in a low prevalence region 181
Ex vivo air–liquid interface respiratory mucosa platform to study type 2–driven asthma 180
Serum Surfactant Protein D as a Marker of Asthma Severity 177
Pharmacological Management of Elderly Patients with Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome: Room for Speculation? 175
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics 175
CT densitometry-based differential diagnosis between emphysematous and non-emphysematous lungs in elderly patients. 174
The Arg/Arg polymorphism of the ADRB2 is associated with the severity of allergic asthma 173
Sleep Disturbances in COPD are Associated with Heterogeneity of Airway Obstruction 172
Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? 171
A 79-year-old-man with SARS-CoV-2 pneumonia and unusual pulmonary co-infection 170
Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients 166
Serum lipoproteins are not associated with the severity of asthma 164
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 164
The geriatric asthma: pitfalls and challenges 161
Distribution and lower limit of normal of computed tomography (CT) density in non emphysematous senile lungs 155
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study 147
Patients with bronchiectasis have a lower combined risk of cardiovascular risk factors and cardiovascular comorbidity compared to patients with COPD 142
The anti-inflammatory properties of tiotropium 141
A novel approach to investigate severe asthma and COPD: the 3d ex vivo respiratory mucosa model 139
Comparison between Suspected and Confirmed COVID-19 Respiratory Patients: What Is beyond the PCR Test 139
Echocardiographic Evaluation of the Cardiac Chambers in Asthmatic Patients: The BADA (Blood Pressure Levels, Clinical Features and Markers of Subclinical Cardiovascular Damage of Asthma Patients) Study-ECO 138
How to unveil chronic respiratory diseases in clinical practice? A model of alliance between general practitioners and pulmonologists 138
Fever and dyspnoea in a tracheostomised patient 138
The impact of SARS-COV2 pandemic on the management oF IPF patients: Our narrative experience 138
Malattie Respiratorie nell’ anziano 137
The asthma-COPD overlap syndrome (ACOS): hype or reality? That is, a curiosity for the media or an opportunity for physicians? 134
The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians 130
Applicability of the MASK-Air® App to Severe Asthma Treated with Biologic Molecules: A Pilot Study 121
Impact of Actively Offering Influenza Vaccination to Frail People during Hospitalisation: A Pilot Study in Italy 120
Transient asymptomatic bradycardia and Remdesivir in COVID-19 patients 119
Valutazione della risposta bronchiale ai respiri profondi mediante HRCT nell’asma e nella BPCO 119
HRCT evaluation of bronchial response to deep inspiration in asthma and chronic obstructive pulmonary disease (COPD) 119
Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression 119
Predictive Biomarkers of Acute Kidney Injury in COVID-19: Distinct Inflammatory Pathways in Patients with and Without Pre-Existing Chronic Kidney Disease 117
Valori di densità TC nella diagnosi differenziale tra polmone senile ed enfisema 117
Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: Tips for facing the second wave 116
The potential role of SP-D as an early biomarker of severity of asthma 114
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 110
Are nighttime respiratory symptoms assessed by asthma control test affected by comorbidities? 107
Severe asthma and COVID-19: lessons from the first wave 104
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 101
Exploring a novel approach to COPD treatment: benralizumab effect in an ex vivo 3-D model 98
Prioritizing care for severe asthma during SARS-CoV-2 pandemic 95
Severe asthma at COVID-19 time: What is new on biologic therapies 95
The multidisciplinary team reduces the time to idiopathic pulmonary fibrosis diagnosis in a real-life setting 87
Serum surfactant protein D and exhaled nitric oxide as biomarkers of early lung damage in systemic sclerosis 86
Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics 85
The prevalence of sleep impairments and predictors of sleep quality among patients with asthma 77
Current status of biological therapy use for older adults with severe asthma 63
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 58
The effects of benralizumab on lung volume changes during exercise in experimental setting in severe asthmatics: a pilot study 57
Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 47
From asthma theory to practice: insights from real life 43
Triple inhaled therapy in asthma: Beliefs, behaviours and doubts 41
Ascending aortic thrombosis in COVID respiratory patient: the “perfect storm” 41
Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK-air study 37
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 36
Coronavirus disease 2019 and severe asthma 29
Adherence to inhaled treatment is associated with better disease control and quality of life in mild-to-moderate asthma 12
null 3
null 3
Totale 12.443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.853
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022554 0 0 35 18 17 33 29 33 103 134 43 109
2022/20231.031 79 196 21 99 106 138 142 70 117 7 40 16
2023/2024465 15 81 19 44 57 82 66 27 6 10 7 51
2024/20251.247 29 86 144 75 43 42 89 74 86 127 173 279
2025/20265.086 327 145 249 365 500 670 693 615 424 402 336 360
2026/2027559 263 239 57 0 0 0 0 0 0 0 0 0
Totale 12.443